Shandong Luoxin Pharmaceutical Group Stock Co (Shandong Luoxin Pharmaceutical Group Stock Co) Accounts Payable & Accrued Expense : $0.0 Mil (As of Mar. 2017)

View and export this data going back to 2009. Start your Free Trial

What is Shandong Luoxin Pharmaceutical Group Stock Co Accounts Payable & Accrued Expense?

Shandong Luoxin Pharmaceutical Group Stock Co's quarterly accounts payable & accrued expense increased from Sep. 2016 ($0.0 Mil) to Dec. 2016 ($185.6 Mil) but then declined from Dec. 2016 ($185.6 Mil) to Mar. 2017 ($0.0 Mil).

Shandong Luoxin Pharmaceutical Group Stock Co's annual accounts payable & accrued expense increased from Dec. 2014 ($92.4 Mil) to Dec. 2015 ($127.4 Mil) and increased from Dec. 2015 ($127.4 Mil) to Dec. 2016 ($185.6 Mil).

Shandong Luoxin Pharmaceutical Group Stock Co Accounts Payable & Accrued Expense Historical Data

The historical data trend for Shandong Luoxin Pharmaceutical Group Stock Co's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shandong Luoxin Pharmaceutical Group Stock Co Accounts Payable & Accrued Expense Chart

Shandong Luoxin Pharmaceutical Group Stock Co Annual Data

Trend

Dec07

Dec08

Dec09

Dec10

Dec11

Dec12

Dec13

Dec14

Dec15

Dec16

Accounts Payable & Accrued Expense

Get a 7-Day Free Trial

64.54

87.98

92.39

127.43

185.65

Shandong Luoxin Pharmaceutical Group Stock Co Quarterly Data
	Jun12	Sep12	Dec12	Mar13	Jun13	Sep13	Dec13	Mar14	Jun14	Sep14	Dec14	Mar15	Jun15	Sep15	Dec15	Mar16	Jun16	Sep16	Dec16	Mar17
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial															-	143.52	-	185.65	-

Shandong Luoxin Pharmaceutical Group Stock Co Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

Shandong Luoxin Pharmaceutical Group Stock Co (Shandong Luoxin Pharmaceutical Group Stock Co) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Shandong Luoxin Pharmaceutical Group Stock Co Ltd (OTCPK:SLUXY) » Definitions » Accounts Payable & Accrued Expense

Traded in Other Exchanges

N/A

Address

Website

http://www.luoxin.cn

Shandong Luoxin Pharmaceutical Group Stock Co Ltd along with its subsidiaries is engaged in the manufacturing and selling of pharmaceutical products. It is involved in the research and development of LXI-15028, a potassium-competitive acid blocker, which is in phase III development for the treatment of reflux esophagitis and other acid-related gastrointestinal diseases; and LXI-15029, an ATP mTOR kinase inhibitor that acts as potent and selective dual inhibitors of mTORC1 and mTORC2 that controls the process of tumor formation and growth. The company mainly operates in the People's Republic of China.

Shandong Luoxin Pharmaceutical Group Stock Co (Shandong Luoxin Pharmaceutical Group Stock Co) Headlines

No Headlines